Wednesday, June 20, 2018 1:43:29 PM
Montreal, QC, June 15, 2018 - Earth Life Sciences Inc. (CLTS) ("Earth Life Sciences" or the "Company") is pleased to update its shareholders in order to clarify certain events regarding the Company.
The management team is considering a proposal for a share consolidation in the form of a one for one thousand (1 for 1000) reverse split.
The share consolidation depends on which one(s) of the various business plans, which are being developed at this time, and will determine the future direction of the Company, are ultimately decided upon.
The reverse split may occur at any time without further notice.
Unsigned, anonymous press releases have been issued in the past. The most recent was released on June 6. These press releases are to be ignored because they have been issued by third parties which are not affiliated with Earth Life Sciences Inc., or its management.
The Company is NOT involved in the cannabis industry.
We urge all shareholders and potential investors to exercise extreme caution in their investment decisions. Do not be taken in by fraudulent press releases.
Only those press releases, which are signed by Angelo Marino, President and CEO of the Company, are official.
Mr. Han Lin has been removed as a director of the Company. He is no longer associated with Earth Life Sciences Inc.
The management of Earth Life Sciences Inc. may be contacted by email at the following address: info@earthlifesciences.net. Our website is www.earthlifesciences.net
All other email addresses are not owned by the Company and will be sent to unknown third parties.
Forward-Looking Statements
These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many risk factors that affect the industry the Company operates in and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Angelo Marino
President and CEO
Earth Life Sciences Inc.
SOURCE Earth Life Sciences Inc.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM